Aurelia Bioscience is a UK based contract research organisation specialising in bioassay development, pharmacological profiling and compound screening. Scientists at Aurelia Bioscience have decades of experience in pre-clinical discovery, designing and developing low, medium and high throughput assays for pharmacological profiling, hits-to-lead, lead identification and lead optimisation. They use cutting edge technologies on a wide range of targets including kinases, GPCRs, PROTAC, proteases, etc to deliver early stage drug discovery projects in a timely, efficient and cost-effective manner.
